Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Matteo Simonelli, Juan Sepulveda, Alba Brandes, Jean-Charles Soria, John Edenfield, Victor Moreno, Jaime Gallego Pérez-Larraya, Carolyn Britten, Timothy F. Cloughesy, Maria Martinez Garcia, Carme Balana, Patrick Hagner, Yan Li, Xin Wei et.al. | ||||||||||||
Title | A PHASE 1A/1B, MULTI-CENTER, OPEN-LABEL DOSE FINDING STUDY TO ASSESS THE SAFETY, TOLERABILITY AND EFFICACY OF THE PLEIOTROPIC PATHWAY MODIFIER CC-122 ADMINISTERED ORALLY TO PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) AND OTHER BRAIN TUMORS | ||||||||||||
|
|||||||||||||
URL | http://neuro-oncology.oxfordjournals.org/content/18/suppl_6/vi24.1.abstract?sid=d99b8d46-acae-4427-baa2-93c7065a25a7 | ||||||||||||
Abstract Text | Neuro Oncol (2016) 18 (suppl 6): vi24. |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|